Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.68137 | 28 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.32555 | 77 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.6791 | 80 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.57117 | 27 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.57326 | 27 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.73533 | 29 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.66103 | 27 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.60684 | 27 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.263 | 52 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.59629 | 26 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.61526 | 27 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.60768 | 28 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.71529 | 31 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.61851 | 27 |